What is your Genotype and which meds are you taking? Also (just out of curiosity) have you treated before?
It says in some places that for dual therapy:
Because there is a clear relationship between ribavirin concentration and sustained virologic response rate, it is preferable not to dose reduce ribavirin if possible, especially in genotype 1 patients.5 In Manns, et al., a regression analysis of sustained virologic response rate and ribavirin dosage shows a clear direct relationship between SVR and dose with a definitive cutoff at a critical dose of 10.6 mg/kg.1 This has led to the argument that adherence to ribavirin dosage improves sustained virologic response rate, although this remains an unproven point to date.6
http://www.hcvadvocate.org/hcsp/articles/Pockros-2.html
But for triple with a Protease Inhibitor (Telaprevir or Boceprevir) a Riba dose reduction is not supposed to
http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/3583-easl-ribavirin-dose-reduction-and-epo-both-work-for-managing-anemia-in-patients-using-boceprevir
There are lots of posts on here related to this topic that elaborate on the guidelines & explain management of hemolytic anemia with the PI's on triple.
http://www.medhelp.org/posts/Hepatitis-C/New-guidelines-say-reduce-Riba-first-for-anemia/show/1620156
http://www.medhelp.org/posts/Hepatitis-C/Procrit-and-ribivirin---dose-adjustment-for-riba/show/1649998